Test of Insomnia Drug Bolsters Vanda's Plan
16th Nov 2006, 17:33 GMT
A few years ago, drug giant Bristol-Myers Squibb Co. announced it was retooling its strategy, meaning a drug it was developing for insomnia was probably headed for the sidelines. Vanda Pharmaceuticals Inc. pounced.
Latest news from washingtonpost.com - Business News From The Washington Post:
- U.S. Commerce Secretary Visits China
- KB Home CEO Bruce Karatz Leaving Firm
- Oct. Budget Deficit Higher Than Last Yr.
- Tribune Stock Up Amid Reports of Bidding
- DOE Vows to Turn Up Appliance Efficiency
- Ask The Post
- KB Chief Leaves Over Options
- Democrats Set to Press U.S. Automakers' Case
- Incorporation Rules Enable Fraud, Officials Warn Panel
- Ford Restates Back Earnings, Gains $850 Million